4.0
October 31, 2023
This update includes underlying architecture improvements and minor reference link updates.
3.0
December 1, 2020
Guidance for patients with acute bleeds on betrixaban has been added, along with updated reversal strategy tables in accordance with the 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants.
More2.0
June 26, 2018
ManageAnticoag helps clinicians navigate periprocedural planning and bleed management scenarios. A clinician can: Enter patient details regarding bleed and stroke risk factors View individualized guidance for that patient on the advice screen Email a summary of the advice The app is derived from ACC’s Expert Consensus Decision Pathways and does not replace clinical judgement. The healthcare provider is in control of all diagnoses and other clinical decisions.
More1.0.1
March 12, 2017
- New app icon
1.0
February 16, 2017
Yes, ManageAnticoag supports iPad devices.
American College of Cardiology launched the ManageAnticoag app.
ManageAnticoag currently supports iOS 12.0 or later.
The ManageAnticoag app has a user rating of 4.8.
The App Genre Of Manageanticoag Is Medical.
The newest version of ManageAnticoag is 4.0.
The latest ManageAnticoag update came out on November 30, 2024.
ManageAnticoag launched on February 5, 2023.
Contains graphic violence, sexual content, or drug use, suitable for adults only.
The ManageAnticoag app is now available in English.
Unfortunately, ManageAnticoag is not on Apple Arcade.
Unfortunately, in-app purchases are not available within ManageAnticoag.
Unfortunately, ManageAnticoag is not optimized for use with Apple Vision Pro.
No, ManageAnticoag does not include ads as part of its experience.